Anxiety Disorders Completed Phase 2 Trials for Baclofen (DB00181)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01751386Baclofen for Treating Anxiety and AlcoholismOther